Back to Search
Start Over
Soft Tissue and Uterine Leiomyosarcoma.
- Source :
-
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Jan 10; Vol. 36 (2), pp. 144-150. Date of Electronic Publication: 2017 Dec 08. - Publication Year :
- 2018
-
Abstract
- Leiomyosarcoma (LMS) is one of the most common subtypes of soft tissue sarcoma in adults and can occur in almost any part of the body. Uterine leiomyosarcoma is the most common subtype of uterine sarcoma. Increased awareness of this unique histology has allowed for the development of drugs that are specific to LMS and has begun to shed light on the similarities and possible unique aspects of soft tissue and uterine LMS. In this review, we summarize the current understanding of the epidemiology, diagnosis, genomics, and treatment options for LMS.
- Subjects :
- Adult
Drug Development
Female
Genomics methods
Humans
Leiomyosarcoma diagnosis
Leiomyosarcoma genetics
Sarcoma diagnosis
Sarcoma genetics
Soft Tissue Neoplasms diagnosis
Soft Tissue Neoplasms genetics
Uterine Neoplasms diagnosis
Uterine Neoplasms genetics
Leiomyosarcoma drug therapy
Sarcoma drug therapy
Soft Tissue Neoplasms drug therapy
Uterine Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1527-7755
- Volume :
- 36
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 29220301
- Full Text :
- https://doi.org/10.1200/JCO.2017.75.9845